Prudential Financial, Inc. (NYSE: PRU) is a Newark, New Jersey-based insurance and financial-services company whose businesses include life insurance, annuities, retirement solutions, and the PGIM investment-management arm, with roughly $1.6 trillion in assets under management. Because the company is a stock, analyst price targets would ordinarily anchor this analysis. However, after a strong 2026 rally, the sell-side has not raised targets fast enough to keep up: the average analyst price target is now about $108, below the stock's recent price near $115.
As a result, this article uses a fallback objective rather than an analyst consensus. The $128 target reflects the stock's 52-week high of about $127.72, a widely followed technical milestone. It is not a guarantee, a forecast, or an official published consensus; it is a concrete level that public market commentary already treats as a meaningful reference point. For context, individual analyst targets currently span roughly $87 to $132, a wide range that underscores how divided the Street is.
PRU traded near $115 in late October 2026, toward the lower end of a 52-week range of roughly $91.89 to $127.72. Reaching $128 would require an advance of about 11% from current levels, a substantial move. The path would likely depend on continued solid results from PGIM, which has been a source of strength, and on progress resolving regulatory and sales-pause issues in Japan. The stock's valuation remains modest relative to the broader market, with a price-to-earnings ratio in the low double digits, which could leave room for multiple expansion if earnings expectations firm up.
Prudential's quarterly results have generally been resilient. Its second-quarter 2026 report showed an earnings-per-share beat and a roughly 10% rise in net investment income, with PGIM delivering healthy margins. Management has set multiyear financial targets through 2027 that include 5% to 8% annual core EPS growth and a 13% to 15% adjusted return on equity. The stock also offers an attractive income component, with a quarterly dividend of $1.40 per share, or about a 4.8% annualized yield, and management has maintained a buyback program that supports per-share results.
The clearest obstacle is the analyst community itself. Recent coverage has tilted firmly toward Hold and Sell ratings, with no consensus Buy ratings, and several firms including Wells Fargo, Morgan Stanley, Barclays, and TD Cowen trimmed targets in October 2026. A sales suspension and conduct review in Japan remain an overhang on the international segment, and passive-competition pressure has limited net flows in asset management. Slower revenue growth, any deterioration in credit or commercial-real-estate exposures, or a broader shift away from value-oriented financial stocks could also keep shares below their prior high.
The $127.72 52-week high is the primary resistance zone that defines the $128 target, and a decisive move above it would represent a breakout to levels not seen in more than a year. On the downside, support has formed near the $110 to $112 area, where several recent analyst targets cluster, with the psychologically important $100 level below that. The 52-week low of about $91.89 marks the lower boundary of the multi-month trading range.
Analyst targets generally reflect a roughly 12-month horizon, though the precise horizon varies by firm. The next quarterly earnings report is due in early November 2026, and consensus estimates point to EPS near $3.39 on sales of about $14.35 billion. Investors should watch the Japan regulatory review, PGIM net flows and margins, dividend and buyback announcements, and any rating or target revisions that follow earnings. Interest-rate decisions and credit-market conditions also matter for a balance-sheet-driven insurer.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to surface new opportunities, keep an eye on existing positions, and spot changing trends more efficiently than by scanning charts manually. For investors tracking PRU, such tools can add an objective, data-driven layer to fundamental research. Explore the signals to see how AI-based monitoring could complement your own process.
Reaching $128 would require PRU to regain its 52-week high and advance roughly 11% from current levels. The case rests on resilient PGIM earnings, a generous dividend, and a modest valuation, while the primary obstacles are the Japan sales-pause overhang and a sell-side that has turned predominantly cautious, with the average analyst target now below the share price. The wide analyst range of roughly $87 to $132 shows genuine disagreement about fair value. Ultimately, whether PRU can retake its prior high depends less on a single catalyst than on whether earnings momentum and resolution of the Japan issues persuade analysts to lift targets back above the market. Investors should monitor the upcoming earnings report and subsequent revisions for the clearest read on that question.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, PRU has been closely correlated with MET. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRU jumps, then MET could also see price increases.